Effect of antiarrhythmic drugs on mortality after myocardial infarction
- 22 September 1983
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 52 (6) , C32-C36
- https://doi.org/10.1016/0002-9149(83)90629-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- INTRAVENOUS AND ORAL DISOPYRAMIDE AFTER MYOCARDIAL INFARCTIONThe Lancet, 1980
- ORAL DISOPYRAMIDE IN PROPHYLAXIS OF ARRHYTHMIAS FOLLOWING MYOCARDIAL INFARCTIONThe Lancet, 1976
- Lidocaine in the Prevention of Primary Ventricular FibrillationNew England Journal of Medicine, 1974
- Prophylactic quinidine for the prevention of arrhythmias after acute myocardial infarctionThe American Journal of Cardiology, 1974
- TRIAL OF COMBINED INTRAMUSCULAR AND INTRAVENOUS LIGNOCAINE IN PROPHYLAXIS OF VENTRICULAR TACHYARRHYTHMIASThe Lancet, 1972
- LIGNOCAINE GIVEN PROPHYLACTICALLY TO PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1971
- CONTROLLED TRIAL OF LIGNOCAINE IN PROPHYLAXIS OF VENTRICULAR ARRHYTHMIAS COMPLICATING MYOCARDIAL INFARCTIONThe Lancet, 1970
- Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial InfarctionNew England Journal of Medicine, 1969
- Prophylactic Quinidine Treatment in Myocardial Infarction: A double blind studyActa Medica Scandinavica, 1967
- PROPHYLACTIC PROCAINE AMIDE IN MYOCARDIAL INFARCTIONHeart, 1961